Cargando…

Multiplex bisulfite PCR resequencing of clinical FFPE DNA

BACKGROUND: The clinical utility of DNA methylation as a predictive or prognostic biomarker requires scalable resequencing protocols for bisulfite-converted DNA. Key features of any validation method should be adaptability for low- or high-throughput needs and high reproducibility, and should only r...

Descripción completa

Detalles Bibliográficos
Autores principales: Korbie, Darren, Lin, Erica, Wall, David, Nair, Shalima S, Stirzaker, Clare, Clark, Sue J, Trau, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389706/
https://www.ncbi.nlm.nih.gov/pubmed/25861392
http://dx.doi.org/10.1186/s13148-015-0067-3
_version_ 1782365604109352960
author Korbie, Darren
Lin, Erica
Wall, David
Nair, Shalima S
Stirzaker, Clare
Clark, Sue J
Trau, Matt
author_facet Korbie, Darren
Lin, Erica
Wall, David
Nair, Shalima S
Stirzaker, Clare
Clark, Sue J
Trau, Matt
author_sort Korbie, Darren
collection PubMed
description BACKGROUND: The clinical utility of DNA methylation as a predictive or prognostic biomarker requires scalable resequencing protocols for bisulfite-converted DNA. Key features of any validation method should be adaptability for low- or high-throughput needs and high reproducibility, and should only require minimal amounts of precious clinical sample as input material. Critically, this method should also deliver robust results when working with bisulfite-converted DNA extracted from formalin-fixed, paraffin-embedded (FFPE) blocks. RESULTS: We report here for the first time on comparison studies between the Fluidigm Access Array system and multiplex assays for multiplex bisulfite PCR resequencing. The requirement of the Fluidigm Access Array system for high template amounts and its sensitivity to variations in template quality rendered it unsuitable for bisulfite PCR applications utilizing FFPE DNA. In response to this limitation, we established a multiplex bisulfite PCR assay capable of delivering robust methylation data using minimal amounts of FFPE clinical DNA. To evaluate the parameters and reproducibility of this assay, 57 amplicons were used to prepare sequencing libraries in triplicate for 13 FFPE tumour samples, as well as a series of 5 methylated controls (0%, 25%, 50%, 75%, and 100%). Analysis of this data demonstrated that this multiplex assay had high reproducibility (mean standard deviation of 1.4% for methylation values), was low cost, required low sample input (50 ng of DNA or less), and could be scaled for both low- and high-throughput needs. Notably, ExoSAP-IT (exonuclease I) treatment to remove residual primers in bisulfite resequencing libraries appeared to degrade the library and generate a high-molecular weight smear which may impact on the degree of methylation assessed. CONCLUSIONS: Multiplex bisulfite PCR assays represent a convenient and scalable method for validation and screening of methylated DNA regions from archival FFPE DNA. Moreover, the library construction process detailed here can be rapidly optimized and implemented with a minimal amount of work, can be performed using the standard equipment found in any molecular biology laboratory, and can be easily adapted for use on both genomic DNA and bisulfite DNA applications. However, in preparing bisulfite libraries for sequencing, the use of ExoSAP-IT is not recommended due to potential off-target nuclease effects which may impact downstream methylation analysis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0067-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4389706
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43897062015-04-09 Multiplex bisulfite PCR resequencing of clinical FFPE DNA Korbie, Darren Lin, Erica Wall, David Nair, Shalima S Stirzaker, Clare Clark, Sue J Trau, Matt Clin Epigenetics Methodology BACKGROUND: The clinical utility of DNA methylation as a predictive or prognostic biomarker requires scalable resequencing protocols for bisulfite-converted DNA. Key features of any validation method should be adaptability for low- or high-throughput needs and high reproducibility, and should only require minimal amounts of precious clinical sample as input material. Critically, this method should also deliver robust results when working with bisulfite-converted DNA extracted from formalin-fixed, paraffin-embedded (FFPE) blocks. RESULTS: We report here for the first time on comparison studies between the Fluidigm Access Array system and multiplex assays for multiplex bisulfite PCR resequencing. The requirement of the Fluidigm Access Array system for high template amounts and its sensitivity to variations in template quality rendered it unsuitable for bisulfite PCR applications utilizing FFPE DNA. In response to this limitation, we established a multiplex bisulfite PCR assay capable of delivering robust methylation data using minimal amounts of FFPE clinical DNA. To evaluate the parameters and reproducibility of this assay, 57 amplicons were used to prepare sequencing libraries in triplicate for 13 FFPE tumour samples, as well as a series of 5 methylated controls (0%, 25%, 50%, 75%, and 100%). Analysis of this data demonstrated that this multiplex assay had high reproducibility (mean standard deviation of 1.4% for methylation values), was low cost, required low sample input (50 ng of DNA or less), and could be scaled for both low- and high-throughput needs. Notably, ExoSAP-IT (exonuclease I) treatment to remove residual primers in bisulfite resequencing libraries appeared to degrade the library and generate a high-molecular weight smear which may impact on the degree of methylation assessed. CONCLUSIONS: Multiplex bisulfite PCR assays represent a convenient and scalable method for validation and screening of methylated DNA regions from archival FFPE DNA. Moreover, the library construction process detailed here can be rapidly optimized and implemented with a minimal amount of work, can be performed using the standard equipment found in any molecular biology laboratory, and can be easily adapted for use on both genomic DNA and bisulfite DNA applications. However, in preparing bisulfite libraries for sequencing, the use of ExoSAP-IT is not recommended due to potential off-target nuclease effects which may impact downstream methylation analysis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0067-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-17 /pmc/articles/PMC4389706/ /pubmed/25861392 http://dx.doi.org/10.1186/s13148-015-0067-3 Text en © Korbie et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Korbie, Darren
Lin, Erica
Wall, David
Nair, Shalima S
Stirzaker, Clare
Clark, Sue J
Trau, Matt
Multiplex bisulfite PCR resequencing of clinical FFPE DNA
title Multiplex bisulfite PCR resequencing of clinical FFPE DNA
title_full Multiplex bisulfite PCR resequencing of clinical FFPE DNA
title_fullStr Multiplex bisulfite PCR resequencing of clinical FFPE DNA
title_full_unstemmed Multiplex bisulfite PCR resequencing of clinical FFPE DNA
title_short Multiplex bisulfite PCR resequencing of clinical FFPE DNA
title_sort multiplex bisulfite pcr resequencing of clinical ffpe dna
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389706/
https://www.ncbi.nlm.nih.gov/pubmed/25861392
http://dx.doi.org/10.1186/s13148-015-0067-3
work_keys_str_mv AT korbiedarren multiplexbisulfitepcrresequencingofclinicalffpedna
AT linerica multiplexbisulfitepcrresequencingofclinicalffpedna
AT walldavid multiplexbisulfitepcrresequencingofclinicalffpedna
AT nairshalimas multiplexbisulfitepcrresequencingofclinicalffpedna
AT stirzakerclare multiplexbisulfitepcrresequencingofclinicalffpedna
AT clarksuej multiplexbisulfitepcrresequencingofclinicalffpedna
AT traumatt multiplexbisulfitepcrresequencingofclinicalffpedna